Retail Innovations of Today and Tomorrow

 

The present is fleeting. What consumers want today may not be the same tomorrow, so for retail strategists to stay on top, they must focus on the future ahead. Inflation and rising prices affect consumer spending today. Will those spending habits change long-term behaviors? What innovations will lead retailers to success from now until the next decade and beyond?  

What Just Happened’s Christine Russo knew to get these answers, she needed a top-notch source. And she found someone whose finger is always on the pulse of the consumer, Kasey Lobaugh, Chief Retail Innovation Office at Deloitte. Lobaugh is currently amid a significant effort at Deloitte focused on the future of the consumer in the more numerous consumer industry, including retail. This year-long effort involves more than five hundred people, including experts and luminaries, both internal and external. Deloitte wants to understand the industry’s various forces over the next decade. 

“We’re still in the process of shaping what it all means,” Lobaugh said. “I can tell you what we’ve come out with is these six forces. And those six forces you must study and understand how they come together. They are accelerating forces, but they are also tectonic. In other words, they’re these big moving pieces slamming into each other.”  

Russo and Lobaugh discuss: 

  • The six forces: consumer, industry, society, technology, planetary climate, and geopolitical changes 
  • Where will the world be in the next decade, and what are the implications 
  •  How the Metaverse and digital experiences will shape consumer spending 

“The future is not something to be predicted; it’s something to be forged,” Lobaugh said. “We play a role, you and I as individuals, and part of what we’re trying to do is understand the critical choices that we, as an industry, will have to make.

Lobaugh is a senior leader In Deloitte’s Retail and Consumer Products practice. He leads Deloitte’s effort to define the forces shaping the next ten years of the Consumer Industry – The Future of Consumers. Lobaugh’s transformed retail initiatives for over 26 years, helping the world’s largest retailers set their strategy for the evolution to a next-gen retail business model. Over his career, Lobaugh’s served most of the world’s largest retailers and has significant global networks within the retail industry. 

 

Follow us on social media for the latest updates in B2B!

Image

Latest

cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More
organoids
Growing the Future of Cancer Research: Inside the Promise of Organoids
April 19, 2025

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…

Read More